Skip to main content
OpenTrials

Clinical trial condition

Muscular Dystrophy, Limb-Girdle, Type 2I

Explore clinical trials studying Muscular Dystrophy, Limb-Girdle, Type 2I. Study availability and eligibility vary by location and protocol.

11 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Muscular Dystrophy, Limb-Girdle, Type 2I trial results

Recruiting

A Study to Evaluate the Safety of AB-1003 (Previously LION-101) in Subjects With Genetic Confirmation of LGMD2I/R9 (Part1)

NCT05230459

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, FKRP, FKRP Mutation, +17 more
Locations
  • University of California - Irvine Irvine, California, United States
  • University of Iowa Iowa City, Iowa, United States
  • University of Kansas Medical Center Kansas City, Kansas, United States
  • Kennedy Krieger Institute Baltimore, Maryland, United States
View Trial Details
Completed

Biomarker Development in LGMD2i

NCT04202627

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Limb Girdle Muscular Dystrophy, +8 more
Locations
  • University of California Irvine Irvine, California, United States
  • University of Colorado Anschutz Medical Campus Aurora, Colorado, United States
  • University of Florida Gainesville, Florida, United States
  • University of Iowa Iowa City, Iowa, United States
View Trial Details
Active, Not Recruiting

Open-Label Extension Study of BBP-418 (Ribitol) for LGMD2I/R9

NCT07678775

Conditions
Limb-Girdle Muscular Dystrophy Type 2I (LGMD2I), Muscular Dystrophy, Limb-Girdle, Type 2I
Locations
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • University of California Irvine Medical Center Orange, California, United States
  • University of Colorado Hospital (UCH) - Anschutz Medical Campus Aurora, Colorado, United States
  • University of Florida Health Center for Pediatric Neuromuscular and Rare Diseases Gainesville, Florida, United States
View all 20 locations
View Trial Details
Active, Not Recruiting

ATA-100 (Formerly GNT0006) Gene Therapy Trial in Patients With LGMDR9

NCT05224505

Conditions
LGMDR9, Muscular Dystrophy, Limb-Girdle, Type 2I
Locations
  • Rigshospitalet, University of Copenhagen Blegdamsvej 9 Copenhagen, Denmark
  • Institute of Myology Pitié-Salpêtrière Hospital 47 Bd de l'Hôpital Paris, France
  • Royal Victoria Infirmary Queen Victoria Road Level 6 Leazes Wing Newcastle upon Tyne, United Kingdom
View Trial Details

Related conditions